Doctor of Podiatric Medicine Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Jerry Liddell

Podiatrist, Foot & Ankle Surgery Saint Louis, MO Doctor of Podiatric Medicine

NPI 1700872611 CMS profile 32294

4901 Forest Park Ave, Div Surg Accs Podiatry, Ste 420, Saint Louis, MO 63108

Open in the dashboard

General payments

$4,772

224 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Jerry Liddell of Saint Louis, MO is reported in the CMS Open Payments database as having received $4,772 across 224 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 66th percentile of Podiatrist, Foot & Ankle Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $264 14
2024 General $500 27
2023 General $1,058 45
2022 General $1,006 40
2021 General $712 30
2020 General $327 10
2019 General $904 58

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Jerry Liddell
  • Podiatrist, Foot & Ankle Surgery median
  • Middle half of Podiatrist, Foot & Ankle Surgery
  • National median

In program year 2025, general payments to Jerry Liddell were reported at $264. Among 6,994 Podiatrist, Foot & Ankle Surgery profiles paid that year, the median was $424 and the middle half received between $139 and $1,306.

Show as a table
Year Jerry Liddell Podiatrist, Foot & Ankle Surgery median Middle half National median
2019 $904 $389 $118–$1,406 $163
2020 $327 $191 $62–$691 $114
2021 $712 $329 $104–$1,341 $132
2022 $1,006 $419 $125–$1,611 $149
2023 $1,058 $377 $128–$1,164 $160
2024 $500 $394 $134–$1,168 $164
2025 $264 $424 $139–$1,306 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Organogenesis Inc. $1,419 75 payments
  2. Integra LifeSciences Corporation $1,228 57 payments
  3. Acera Surgical, Inc. $468 18 payments
  4. Smith+Nephew, Inc. $396 34 payments
  5. Kerecis Limited $259 5 payments
  6. KCI USA, Inc $180 3 payments
  7. Hydrofera LLC $129 3 payments
  8. Wright Medical Technology, Inc. $125 4 payments
  9. Horizon Therapeutics plc $116 1 payment
  10. ProgenaCare Global, LLC $68 1 payment
  11. Other $382 23 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $4,772 224 payments
Products named General payments · program years 2019–2025
  1. PRIMATRIX Recon-Skin And Wound $977 47 payments
  2. INTEGRA DERMAL REGENERATION TEMPLATE $977 47 payments
  3. Integra Recon-Skin And Wound $785 41 payments
  4. Integra Recon-Skin And Wound $785 41 payments
  5. Integra Recon-Skin And Wound $785 41 payments
  6. Puraply $575 39 payments
  7. Restrata Wound Matrix $286 9 payments
  8. Kerecis Omega3 SurgiClose $246 3 payments
  9. TCC-EZ $233 9 payments
  10. PRIMATRIX Recon-Skin And Wound $233 9 payments
  11. Other $4,733 177 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 4 drugs

Part D claims

66

Median for Podiatry: 160

Drug cost

$1,300

Median for Podiatry: $2,368

Branded share of claims

0%

Median for Podiatry: 12.7%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Ammonium Lactate Generic 28 $932
Clotrimazole Generic 12 $187
Doxycycline Hyclate Generic 14 $116
Gabapentin Generic 12 $66

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 14,093 Part D prescribers listed as Podiatry; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 39 billing codes

Paid by Medicare

$49,921

Medicare's payments for the services billed

Medicare patients

223

Average age 70

Services billed

863

91 women, 132 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Diabetes 70%
Chronic kidney disease 59%
Arthritis 58%
Ischemic heart disease 49%
Heart failure 48%
Atrial fibrillation 35%
Depression 34%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

224 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Podiatrist, Foot & Ankle Surgery in Missouri

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record